LU85721A1 - Compose antibiotique,procede pour le preparer et compositions le contenant - Google Patents
Compose antibiotique,procede pour le preparer et compositions le contenant Download PDFInfo
- Publication number
- LU85721A1 LU85721A1 LU85721A LU85721A LU85721A1 LU 85721 A1 LU85721 A1 LU 85721A1 LU 85721 A LU85721 A LU 85721A LU 85721 A LU85721 A LU 85721A LU 85721 A1 LU85721 A1 LU 85721A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- stearate
- erythromycin
- acetyl
- erythromycin stearate
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK5884 | 1984-01-06 | ||
| DK5884A DK149776C (da) | 1984-01-06 | 1984-01-06 | Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU85721A1 true LU85721A1 (fr) | 1985-07-24 |
Family
ID=8089251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU85721A LU85721A1 (fr) | 1984-01-06 | 1985-01-04 | Compose antibiotique,procede pour le preparer et compositions le contenant |
Country Status (38)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
| US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
| JP3382159B2 (ja) * | 1998-08-05 | 2003-03-04 | 株式会社東芝 | 情報記録媒体とその再生方法及び記録方法 |
| US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| JP4694207B2 (ja) * | 2002-07-05 | 2011-06-08 | コルジウム ファーマシューティカル， インコーポレイテッド | オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物 |
| US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| AU2004285533A1 (en) * | 2003-10-31 | 2005-05-12 | Alza Corporation | Compositions and dosage forms for enhanced absorption |
| CA2569958C (en) | 2004-06-12 | 2016-03-22 | Jane C. Hirsh | Abuse-deterrent drug formulations |
| EP2457580A1 (en) | 2004-08-25 | 2012-05-30 | The UAB Research Foundation | Absorption enhancers for drug administration |
| US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
| WO2007149096A1 (en) | 2006-06-23 | 2007-12-27 | Aegis Therapeutics, Inc. | Stabilizing alkylglycoside compositions and methods thereof |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| EP3566711A1 (en) | 2011-05-18 | 2019-11-13 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
| EP2922877B1 (en) | 2012-11-20 | 2018-09-05 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
| KR102213907B1 (ko) | 2012-11-20 | 2021-02-09 | 메더리스 다이어비티즈, 엘엘씨 | 인슐린 저항성에 대한 개선된 펩티드 약제 |
| WO2014140699A1 (en) * | 2013-03-13 | 2014-09-18 | Calyx Chemicals And Pharmaceuticals Ltd | A novel process of liberation of erythromycin and preparation of its salts |
| PL3155017T4 (pl) | 2014-05-28 | 2024-06-17 | Mederis Diabetes, Llc | Ulepszone farmaceutyki peptydowe dla insulinooporności |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| CA3063717C (en) | 2017-05-19 | 2021-08-24 | Lunella Biotech, Inc. | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| WO2019108729A1 (en) | 2017-12-01 | 2019-06-06 | Lunella Biotech, Inc. | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| RS63866B1 (sr) | 2018-02-06 | 2023-01-31 | Aegis Therapeutics Llc | Intranazalne formulacije epinefrina i postupci za lečenje bolesti |
| BR112021011963A2 (pt) * | 2018-12-17 | 2021-09-08 | Lunella Biotech, Inc. | Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer |
| JP7641897B2 (ja) * | 2018-12-17 | 2025-03-07 | ルネラ・バイオテック・インコーポレーテッド | 抗加齢のための三剤組合せ療法 |
| EA202091615A1 (ru) | 2018-12-21 | 2021-03-05 | Аегис Терапьютикс, Ллс | Интраназальные составы на основе эпинефрина и способы лечения заболевания |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1011117B (de) * | 1953-11-16 | 1957-06-27 | Abbott Lab | Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen |
| FR1179208A (fr) * | 1953-11-16 | 1959-05-21 | Abbott Lab | Procédé de préparation de sels d'érythromycine |
| GB834397A (en) * | 1958-07-29 | 1960-05-04 | Lilly Co Eli | Therapeutic compositions comprising erythromycin esters |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| FR2473525A1 (fr) * | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-01-06 DK DK5884A patent/DK149776C/da not_active IP Right Cessation
- 1984-12-18 NZ NZ210606A patent/NZ210606A/en unknown
- 1984-12-20 IL IL73885A patent/IL73885A/xx not_active IP Right Cessation
- 1984-12-21 GB GB08432368A patent/GB2152502B/en not_active Expired
- 1984-12-21 AU AU37059/84A patent/AU565688B2/en not_active Ceased
- 1984-12-27 US US06/686,753 patent/US4599326A/en not_active Expired - Fee Related
- 1984-12-28 IS IS2968A patent/IS2968A7/is unknown
- 1984-12-28 SE SE8406671A patent/SE461854B/sv not_active IP Right Cessation
- 1984-12-28 PT PT79777A patent/PT79777B/pt not_active IP Right Cessation
- 1984-12-28 BE BE0/214265A patent/BE901411A/fr not_active IP Right Cessation
- 1984-12-28 ZA ZA8410143A patent/ZA8410143B/xx unknown
- 1984-12-31 NL NL8403979A patent/NL8403979A/nl not_active Application Discontinuation
-
1985
- 1985-01-02 MA MA20540A patent/MA20316A1/fr unknown
- 1985-01-02 FR FR8500005A patent/FR2557878B1/fr not_active Expired
- 1985-01-02 NO NO850007A patent/NO160263C/no unknown
- 1985-01-03 AT AT0000985A patent/AT386414B/de not_active IP Right Cessation
- 1985-01-03 FI FI850023A patent/FI77249C/fi not_active IP Right Cessation
- 1985-01-04 PL PL1985251457A patent/PL144349B1/pl unknown
- 1985-01-04 SU SU853836820A patent/SU1410866A3/ru active
- 1985-01-04 LU LU85721A patent/LU85721A1/fr unknown
- 1985-01-04 YU YU20/85A patent/YU44485B/xx unknown
- 1985-01-04 IT IT19012/85A patent/IT1184304B/it active
- 1985-01-04 HU HU8537A patent/HU196221B/hu not_active IP Right Cessation
- 1985-01-04 CS CS8596A patent/CS247191B2/cs unknown
- 1985-01-04 DE DE19853500179 patent/DE3500179A1/de active Granted
- 1985-01-04 IE IE22/85A patent/IE57967B1/en not_active IP Right Cessation
- 1985-01-04 KR KR1019850000008A patent/KR900006237B1/ko not_active Expired
- 1985-01-04 ES ES539349A patent/ES8605818A1/es not_active Expired
- 1985-01-04 CA CA000471563A patent/CA1224461A/en not_active Expired
- 1985-01-04 CH CH31/85A patent/CH666275A5/de not_active IP Right Cessation
- 1985-01-05 BG BG068285A patent/BG43189A3/xx unknown
- 1985-01-07 PH PH31689A patent/PH22471A/en unknown
- 1985-01-07 RO RO117230A patent/RO91262B/ro unknown
- 1985-01-07 JP JP60000744A patent/JPS60158197A/ja active Granted
- 1985-01-07 MX MX203973A patent/MX156277A/es unknown
-
1988
- 1988-10-28 KE KE3841A patent/KE3841A/xx unknown
-
1989
- 1989-07-21 CY CY1462A patent/CY1462A/en unknown
-
1990
- 1990-02-15 HK HK115/90A patent/HK11590A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU85721A1 (fr) | Compose antibiotique,procede pour le preparer et compositions le contenant | |
| CH646412A5 (fr) | Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits. | |
| FR2502153A1 (fr) | Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant | |
| CN103228668A (zh) | 抗糖尿病的苯基丙酮酸烯醇糖苷 | |
| BE1000573A4 (fr) | Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant. | |
| FR2495160A1 (fr) | Derive de bisglucosylmoranoline et compositions pharmaceutiques pour le traitement du diabete sucre qui le renferment | |
| LU85716A1 (fr) | Procede de preparation d'un nouveau compose complexe d'hemine ayant des applications medicales | |
| LU84428A1 (fr) | Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique,leurs sels,leur preparation,leur application comme medicaments et les compositions les renfermant | |
| CA1199582A (fr) | Forme medicamenteuse de theophylline a action prolongee | |
| CN116157120B (zh) | 包含苯并呋喃基n-酰腙衍生物的抗炎组合物 | |
| EP0117171B1 (fr) | Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant | |
| MC898A1 (fr) | Composés organiques | |
| CA2075291C (fr) | Nouvel agent antitumoral derive du dextrane | |
| LU84429A1 (fr) | A titre de medicaments,certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| CH637650A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| FR2547821A1 (fr) | Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant | |
| WO1981002295A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| FR2619010A1 (fr) | Composition pharmaceutique antivirale comprenant de la 5-isopropyl-2'-b-deoxyuridine, s'accumulant dans la peau, applicable par voie externe et procede pour sa preparation | |
| FR2801055A1 (fr) | Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique | |
| CN116265463B (zh) | 一种醛糖还原酶抑制剂的晶型及其制备方法和应用 | |
| EP0155872A1 (fr) | Procédé de réduction du taux de lignine dans les végétaux et nouvelles compositions pour sa mise en oeuvre | |
| EP1007522B1 (fr) | 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique | |
| BE875451A (fr) | Nouveaux medicaments constitues de derives de l'acide p-amino-benzoique | |
| FR2471984A1 (fr) | Derives de l'acide aminobenzoique et leur utilisation pour preparer des compositions pharmaceutiques | |
| JPH0959249A (ja) | 抗菌剤及び医薬組成物 |